Related references
Note: Only part of the references are listed.Macrophage activation and polarization
Fernando Oneissi Martinez et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4) - A novel strategy for the treatment of melanoma and other malignancies
Steven J. O'Day et al.
CANCER (2007)
The frequency and suppressor function of CD4+CD25high Foxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck
Laura Strauss et al.
CLINICAL CANCER RESEARCH (2007)
Tumor necrosis factor α as a new target for renal cell carcinoma:: Two sequential phase II trials of infliximab at standard and high dose
Michelle L. Harrison et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Tumor microenvironment and immune escape
Soldano Ferrone et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2007)
Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma
Christoph Bergmann et al.
CANCER RESEARCH (2007)
A unique subset of CD4+CD25high Foxp3+ T cells secreting interleukin-10 and transforming growth factor-β1 mediates suppression in the tumor microenvironment
Laura Strauss et al.
CLINICAL CANCER RESEARCH (2007)
Dual role of mitochondrial reactive oxygen species in hypoxia signaling:: Activation of nuclear factor-κB via c-SRC- and oxidant-dependent cell death
Josep M. Lluis et al.
CANCER RESEARCH (2007)
Role of regulatory T cells and FOXP3 in human diseases
Rosa Bacchetta et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor based antitumor vaccine
Paola Filipazzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Depletion of CD4+CD25+ human regulatory T cells in vivo:: Kinetics of Treg depletion and alterations in immune functions in vivo and in vitro
Karsten Mahnke et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
David H. Munn et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
CD25+ regulatory T cell inhibition enhances vaccine-induced immunity to neuroblastoma
Bryon D. Johnson et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Depleting intratumoral CD4+CD25+ regulatory T cells via FasL protein transfer enhances the therapeutic efficacy of adoptive T cell transfer
Aoshuang Chen et al.
CANCER RESEARCH (2007)
Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma
Augusto C. Ochoa et al.
CLINICAL CANCER RESEARCH (2007)
Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity
Smita Nair et al.
CANCER RESEARCH (2007)
The adaptive immunologic microenvironment in colorectal cancer: A novel perspective
Jerome Galon et al.
CANCER RESEARCH (2007)
Macrophages from irradiated tumors express higher levels of iNOS, Arginase-I and COX-2, and promote tumor growth
Chien-Sheng Tsai et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Selective survival of naturally occurring human CD4(+)CD25(+)Foxp3(+) regulatory T cells cultured with rapamycin
Laura Strauss et al.
JOURNAL OF IMMUNOLOGY (2007)
Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8(+) T-cell response to reptide vaccination: Creation of a beneficial host microenvironment involving type IIFNs and myeloid cells
Mohamed L. Salem et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients
Devi K. Banerjee et al.
BLOOD (2006)
Cancer despite immunosurveillance: immunoselection and immunosubversion
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells
Giovanna Gallina et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Dendritic cells and tumor microenvironment: A dangerous liaison
Ingo Fricke et al.
IMMUNOLOGICAL INVESTIGATIONS (2006)
Immune suppression in cancer: Effects on immune cells, mechanisms and future therapeutic intervention
TL Whiteside
SEMINARS IN CANCER BIOLOGY (2006)
Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppression
P Serafini et al.
SEMINARS IN CANCER BIOLOGY (2006)
Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines
G Zhou et al.
BLOOD (2006)
Effector memory T cells, early metastasis, and survival in colorectal cancer
F Pagès et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Cutting edge:: Contact-mediated suppression by CD4+-CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism
DC Gondek et al.
JOURNAL OF IMMUNOLOGY (2005)
Animal models of tumor immunity, immunotherapy and cancer vaccines
S Ostrand-Rosenberg
CURRENT OPINION IN IMMUNOLOGY (2004)
NF-κB functions as a tumour promoter in inflammation-associated cancer
E Pikarsky et al.
NATURE (2004)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer
FR Greten et al.
CELL (2004)
Selective growth, in vitro and in vivo, of individual T cell clones from tumor-infiltrating lymphocytes obtained from patients with melanoma
JH Zhou et al.
JOURNAL OF IMMUNOLOGY (2004)
Elevated TGF-β1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients
JC Lee et al.
JOURNAL OF IMMUNOLOGY (2004)
Investigating hypoxic tumor physiology through gene expression patterns
NC Denko et al.
ONCOGENE (2003)
L-arginine metabolism in myeloid cells controls T-lymphocyte functions
V Bronte et al.
TRENDS IN IMMUNOLOGY (2003)
Natural killer cell receptor signaling
LL Lanier
CURRENT OPINION IN IMMUNOLOGY (2003)
Response to Hellstrand: The jury on radicals is still out
A Mantovani et al.
TRENDS IN IMMUNOLOGY (2003)
CD4(+)CD25(+) T cells lyse antigen-presenting B cells by Fas-Fas ligand interaction in an epitope-specific manner
W Janssens et al.
JOURNAL OF IMMUNOLOGY (2003)
Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma
UK Liyanage et al.
JOURNAL OF IMMUNOLOGY (2002)
Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast
JA Coronella et al.
JOURNAL OF IMMUNOLOGY (2002)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Danger signals: SOS to the immune system
S Gallucci et al.
CURRENT OPINION IN IMMUNOLOGY (2001)
Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer
B Almand et al.
JOURNAL OF IMMUNOLOGY (2001)
Growth regulated oncogene-α expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism
E Loukinova et al.
ONCOGENE (2000)